121 related articles for article (PubMed ID: 11468963)
1. Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
McMorran M; Vu D
CMAJ; 2001 Jul; 165(1):82-3, 86-7. PubMed ID: 11468963
[No Abstract] [Full Text] [Related]
2. Troglitazone-associated hepatic failure.
Booth AM; Caldwell SH; Iezzoni JC
Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
[No Abstract] [Full Text] [Related]
3. Liver failure in a patient treated with long-term rosiglitazone therapy.
Gouda HE; Khan A; Schwartz J; Cohen RI
Am J Med; 2001 Nov; 111(7):584-5. PubMed ID: 11705443
[No Abstract] [Full Text] [Related]
4. Rosiglitazone toxicity.
Ravinuthala RS; Nori U
Ann Intern Med; 2000 Oct; 133(8):658. PubMed ID: 11033603
[No Abstract] [Full Text] [Related]
5. Correction: Liver injury and rosiglitazone.
Ann Intern Med; 2000 Aug; 133(3):237. PubMed ID: 10906846
[No Abstract] [Full Text] [Related]
6. Isolated elevation of alkaline phosphatase level associated with rosiglitazone.
Hachey DM; O'Neil MP; Force RW
Ann Intern Med; 2000 Nov; 133(9):752. PubMed ID: 11074926
[No Abstract] [Full Text] [Related]
7. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
Osei SY; Koro CE; Cobitz AR; Kolatkar NS; Stender M
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1244-6. PubMed ID: 19655316
[No Abstract] [Full Text] [Related]
8. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
Beiderbeck AB; Sakaguchi M
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1247-9. PubMed ID: 19842093
[No Abstract] [Full Text] [Related]
9. Hepatocellular injury in a patient receiving rosiglitazone. A case report.
Al-Salman J; Arjomand H; Kemp DG; Mittal M
Ann Intern Med; 2000 Jan; 132(2):121-4. PubMed ID: 10644273
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone-induced granulomatous hepatitis.
Dhawan M; Agrawal R; Ravi J; Gulati S; Silverman J; Nathan G; Raab S; Brodmerkel G
J Clin Gastroenterol; 2002; 34(5):582-4. PubMed ID: 11960075
[TBL] [Abstract][Full Text] [Related]
11. Lessons from the glitazones: a story of drug development.
Gale EA
Lancet; 2001 Jun; 357(9271):1870-5. PubMed ID: 11410214
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone-associated hepatic failure.
Misbin RI
Ann Intern Med; 1999 Feb; 130(4 Pt 1):330. PubMed ID: 10068399
[No Abstract] [Full Text] [Related]
13. Pioglitazone-associated fulminant hepatic failure.
Chase MP; Yarze JC
Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
[No Abstract] [Full Text] [Related]
14. Rapid-onset subfulminant liver failure associated with troglitazone.
Jagannath S; Rai R
Ann Intern Med; 2000 Apr; 132(8):677. PubMed ID: 10766693
[No Abstract] [Full Text] [Related]
15. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.
Chan KA; Truman A; Gurwitz JH; Hurley JS; Martinson B; Platt R; Everhart JE; Moseley RH; Terrault N; Ackerson L; Selby JV
Arch Intern Med; 2003 Mar; 163(6):728-34. PubMed ID: 12639207
[TBL] [Abstract][Full Text] [Related]
16. Case series of liver failure associated with rosiglitazone and pioglitazone.
Floyd JS; Barbehenn E; Lurie P; Wolfe SM
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone and hepatic failure.
Freid J; Everitt D; Boscia J
Ann Intern Med; 2000 Jan; 132(2):164. PubMed ID: 10644281
[No Abstract] [Full Text] [Related]
18. [Meta-analysis shows: insulin sensitizer is safe for the liver].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440297
[No Abstract] [Full Text] [Related]
19. Substituting for troglitazone (Rezulin).
Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
[No Abstract] [Full Text] [Related]
20. Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.
Wooltorton E
CMAJ; 2002 Jan; 166(2):219. PubMed ID: 11826947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
